Vivos Therapeutics opens Henderson, Nevada sleep testing and treatment center, targets over $10 million annual capacityPUBT·11 hours agoVVOS+1.23%
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment | VVOS Stock NewsStockTitan·19 hours agoVVOS+1.23%
Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Revenue Up 35%, Liquidity Risks PersistTradingKey·Aug 17 at 03:02 AMVVOS+1.23%
Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcriptbenzinga_article·Aug 14 at 05:37 PMVVOS+1.23%
Vivos Therapeutics announces Q2 2026 financials with operational update.Unusual Whales·Aug 14 at 03:30 PMVVOS+1.23%
Vivos Therapeutics Q2 FY26 net loss widens to $5.52 million; revenue rises 35% to $5.2 millionPUBT·Aug 14 at 03:29 PMVVOS+1.23%
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call | VVOS Stock NewsStockTitan·Aug 13 at 11:45 PMVVOS+1.23%
Vivos net loss widens to $2.02 million in 1H FY26; revenue rises to $72,468PUBT·Aug 12 at 03:35 PMVVOS+1.23%
Vivos Therapeutics issues new US patent broadening protection for Vivos CARE devicesTradingView·Aug 11 at 04:13 PMVVOS+1.23%
Vivos Therapeutics kantongi paten AS baru untuk teknologi perangkat oral Vivos CAREPUBT·Aug 11 at 04:06 PMVVOS+1.23%
